Comparative analysis of anxiety and depression prevalence between individuals with and without inflammatory bowel disease

Xavier, 2007, Unravelling the pathogenesis of inflammatory bowel disease, Nature., 448, 427, 10.1038/nature06005 Zaterka, 2016 Szigethy E, Weaver E, Click B, Kogan J, Shrank W, Mcauliff K, et al. Psychiatric Characterization of Patients Enrolled in IBD Subspecialty Home. Am J Gastroenterol. February 2018;113:S2. Cardozo, 2015, 614 Graff, 2009, Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management, Inflamm Bowel Dis., 15, 1105, 10.1002/ibd.20873 Souza, 2008, Perfil epidemiológico dos pacientes portadores de doença inflamatória intestinal do estado de Mato Grosso, Rev Bras Coloproctol., 28, 324, 10.1590/S0101-98802008000300009 Spitzer, 2006, A brief measure for assessing generalized anxiety disorder: the GAD-7, Arch Intern Med., 166, 1092, 10.1001/archinte.166.10.1092 Kroenke, 2007, Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection, Ann Intern Med., 146, 317, 10.7326/0003-4819-146-5-200703060-00004 Bergerot, 2014, Avaliação de ansiedade e depressão em pacientes oncológicos: comparação psicométrica, Psico-USF., 19, 187, 10.1590/1413-82712014019002004 Kroenke, 2002, The PHQ-9: a new depression diagnostic and severity measure, Psychiatr Ann., 32, 509, 10.3928/0048-5713-20020901-06 Martin, 2006, Validity of the brief patient health questionnaire mood scale (PHQ-9) in the general population, Gen Hosp Psychiatry., 28, 71, 10.1016/j.genhosppsych.2005.07.003 Osório, 2009, Study of the discriminative validity of the PHQ-9 and PHQ-2 in a sample of Brazilian women in the context of primary health care, Perspect Psychiatr Care., 45, 216, 10.1111/j.1744-6163.2009.00224.x Bernstein, 2018, CIHR Team in Defining the Burden and Managing the Effects of Immune-mediated Inflammatory Disease. The validity and reliability of screening measures for depression and anxiety disorders in inflammatory bowel disease, Inflamm Bowel Dis., 24, 1867, 10.1093/ibd/izy068 Starcevic, 2013, The status quo as a good outcome: how the DSM-5 diagnostic criteria for generalized anxiety disorder remained unchanged from the DSM-IV criteria, Aust N Z J Psychiatry., 47, 995, 10.1177/0004867413503719 Arantes, 2017, Epidemiological profile and clinical characteristics of patients with intestinal inflammatory disease, J Coloproctol. (Rio J.)., 37, 273, 10.1016/j.jcol.2017.06.004 Shirazi, 2013, Epidemiological and clinical characteristics of inflammatory bowel disease in patients from northwestern Iran, Middle East J Dig Dis., 5, 86 Rubin, 2016, The Crohn's and colitis foundation of america survey of inflammatory bowel disease patient health care access, Inflamm Bowel Dis., 23, 224, 10.1097/MIB.0000000000000994 Kochar, 2018, Depression is associated with more aggressive inflammatory bowel disease, Am J Gastroenterol., 113, 80, 10.1038/ajg.2017.423 Petroski, 2009, Estágios de mudança de comportamento e percepção positiva do ambiente para atividade física em usuários de parque urbano, Motricidade., 5, 17, 10.6063/motricidade.5(2).179 Neuendorf, 2016, Depression and anxiety in patients with Inflammatory Bowel Disease: a systematic review, J Psychosom Res, 87, 70, 10.1016/j.jpsychores.2016.06.001 Molina, 2012, Prevalência de depressão em usuários de unidades de atenção primária, Rev Psiq Clín., 39, 194, 10.1590/S0101-60832012000600003 Organização Mundial de Saúde-OMS, 2017 Häuser, 2011, Anxiety and depression in patients with inflammatory bowel disease: comparisons with chronic liver disease patients and the general population, Inflamm Bowel Dis., 17, 621, 10.1002/ibd.21346 Addolorato, 1997, Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status, Scand J Gastroenterol, 32, 1013, 10.3109/00365529709011218 Falcão, 2016, Associação de doença inflamatória intestinal com ansiedade e depressão: avaliação dos fatores de risco, GED Gastroenterol Endosc Dig., 35, 52 Cohen, 2002, The quality of life in patients with Crohn’s disease, Aliment Pharmacol Ther., 16, 1603, 10.1046/j.1365-2036.2002.01323.x Bernklev, 2005, Health-related quality of life in patients with inflammatory bowel disease measured with the Short Form-36: psychometric assessments and a comparison with general population norms, Inflamm Bowel Dis., 11, 909, 10.1097/01.mib.0000179467.01748.99 Janke, 2005, Determinants of life satisfaction in inflammatory bowel disease, Inflamm Bowel Dis., 11, 272, 10.1097/01.MIB.0000160809.38611.f7 Bonaz, 2013, Brain-gut interactions in inflammatory bowel disease, Gastroenterology. WB Saunders, 144, 36, 10.1053/j.gastro.2012.10.003 Martin-Subero, 2016, Comorbidity between depression and inflammatory bowel disease explained by imune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolit; and gut-brain pathways, CNS Spectr., 21, 184, 10.1017/S1092852915000449 Kiebles, 2010, Preliminary evidence supporting a framework of psychological adjustment to inflammatory bowel disease, Inflammatory Bowel Dis., 16, 1685, 10.1002/ibd.21215 Byrne, 2017, Prevalence of anxiety and depression in patients with inflammatory bowel disease, Can J Gastroenterol Hepatol., 2017, 10.1155/2017/6496727 Mikocka-Walus, 2016, Cohort Study Group. Symptoms of depression and anxiety are independently associated with clinical recurrence of inflammatory bowel disease, Clin Gastroenterol Hepatol., 14, 829, 10.1016/j.cgh.2015.12.045 Spiller, 2012, Transtornos intestinais, Ar Gastroenterol., 49, 39, 10.1590/S0004-28032012000500008 Lewis, 2019, CIHR Team in defining the burden and managing the effects of immune-mediated inflammatory disease. The prevalence and risk factors of undiagnosed depression and anxiety disorders among patients with inflammatory bowel disease, Inflamm Bowel Dis., 25, 1674, 10.1093/ibd/izz045 Nakagawa, 2017, Association of anxiety and depression with pain and quality of life in patients with chronic foot and ankle diseases, Foot Ankle Int., 38, 1192, 10.1177/1071100717723133 Moussavi, 2007, Depression, chronic diseases, and decrements in health: results from the World Health Surveys, Lancet., 370, 851, 10.1016/S0140-6736(07)61415-9 Liu, 2017, Evidence for inflammation-associated depression, Curr Top Behav Neurosci., 31, 3, 10.1007/7854_2016_2 Leonard, 2018, Inflammation and depression: a causal or coincidental link to the pathophysiology, Acta Neuropsychiatr., 30, 1, 10.1017/neu.2016.69 Pierone, 2016, Qualidade de vida de usuários de parques públicos, Boletim Psicol., 66, 99 Dunn, 2001, Physical activity dose-response effects on outcomes of depression and anxiety. In Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet], Centre for Reviews and Dissemination (UK). Rebar, 2015, A meta-meta-analysis of the effect of physical activity on depression and anxiety in non-clinical adult populations, Health Psychol Rev., 9, 366, 10.1080/17437199.2015.1022901 Burisch, 2015, The epidemiology of inflammatory bowel disease, Scandinavian J Gastroenterol., 50, 942, 10.3109/00365521.2015.1014407